Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Allergy Clin Immunol. 2016 Aug 10;139(1):173–181.e8. doi: 10.1016/j.jaci.2016.05.027

Figure 3.

Figure 3

Figure 3

Association of baseline peanut-specific IgE characteristics and outcomes. (A) Both the baseline peanut-specific IgE, and the ratio of peanut-specific to total IgE, are significantly lower among successes than failures in the ITT population. (B) Length of treatment broken down by tertiles of baseline peanut-specific IgE. Significance testing by one-way ANOVA.